A federal judge declined to block the Biden administration’s mail-order abortion scheme last week — but he put the U.S. Food and Drug Administration (FDA) on notice as the agency continues its safety review of the abortion drug mifepristone.
U.S. District Judge David Joseph ruled against Louisiana Attorney General Liz Murrill, who asked the court to halt an FDA rule that allows mifepristone to be dispensed through mail as litigation challenging the rule continues. Joseph issued a 37-page memorandum ruling granting the Trump administration’s request to pause the case as the FDA continues its “good-faith, evidence-based and expeditious review”…
Read the full article at BREITBART.COM







